These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
689 related items for PubMed ID: 18582864
1. Memantine prevents the cognitive impairment induced by 3,4-methylenedioxymethamphetamine in rats. Camarasa J, Marimón JM, Rodrigo T, Escubedo E, Pubill D. Eur J Pharmacol; 2008 Jul 28; 589(1-3):132-9. PubMed ID: 18582864 [Abstract] [Full Text] [Related]
2. Memantine is a useful drug to prevent the spatial and non-spatial memory deficits induced by methamphetamine in rats. Camarasa J, Rodrigo T, Pubill D, Escubedo E. Pharmacol Res; 2010 Nov 28; 62(5):450-6. PubMed ID: 20553881 [Abstract] [Full Text] [Related]
3. Memantine and recognition memory: possible facilitation of its behavioral effects by the nitric oxide (NO) donor molsidomine. Pitsikas N, Sakellaridis N. Eur J Pharmacol; 2007 Oct 01; 571(2-3):174-9. PubMed ID: 17628527 [Abstract] [Full Text] [Related]
4. Cognitive dysfunction induced by sequential injection of amyloid-beta and ibotenate into the bilateral hippocampus; protection by memantine and MK-801. Nakamura S, Murayama N, Noshita T, Katsuragi R, Ohno T. Eur J Pharmacol; 2006 Oct 24; 548(1-3):115-22. PubMed ID: 16952349 [Abstract] [Full Text] [Related]
5. Involvement of nicotinic receptors in methamphetamine- and MDMA-induced neurotoxicity: pharmacological implications. Escubedo E, Camarasa J, Chipana C, García-Ratés S, Pubill D. Int Rev Neurobiol; 2009 Oct 24; 88():121-66. PubMed ID: 19897077 [Abstract] [Full Text] [Related]
7. Cognition-enhancing and anxiolytic effects of memantine. Minkeviciene R, Banerjee P, Tanila H. Neuropharmacology; 2008 Jun 20; 54(7):1079-85. PubMed ID: 18378262 [Abstract] [Full Text] [Related]
8. Memantine reduces oxidative damage and enhances long-term recognition memory in aged rats. Pietá Dias C, Martins de Lima MN, Presti-Torres J, Dornelles A, Garcia VA, Siciliani Scalco F, Rewsaat Guimarães M, Constantino L, Budni P, Dal-Pizzol F, Schröder N. Neuroscience; 2007 Jun 08; 146(4):1719-25. PubMed ID: 17445991 [Abstract] [Full Text] [Related]
9. Effects of the cognition impairer MK-801 on learning and memory in mice and rats. van der Staay FJ, Rutten K, Erb C, Blokland A. Behav Brain Res; 2011 Jun 20; 220(1):215-29. PubMed ID: 21310186 [Abstract] [Full Text] [Related]
10. Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat. Grayson B, Idris NF, Neill JC. Behav Brain Res; 2007 Nov 22; 184(1):31-8. PubMed ID: 17675172 [Abstract] [Full Text] [Related]
11. Subchronic MK-801 behavioural deficits in rats: partial reversal by the novel nitrate GT 1061. Beninger RJ, Forsyth JK, Van Adel M, Reynolds JN, Boegman RJ, Jhamandas K. Pharmacol Biochem Behav; 2009 Feb 22; 91(4):495-502. PubMed ID: 18834899 [Abstract] [Full Text] [Related]
12. Memantine prevents progressive functional neurodegeneration in rats. Heim C, Sontag KH. J Neural Transm Suppl; 1995 Feb 22; 46():117-30. PubMed ID: 8821047 [Abstract] [Full Text] [Related]
13. Functional alteration by NMDA antagonist: effects of L-Dopa, neuroleptics drug and postnatal administration. Fredriksson A, Archer T. Amino Acids; 2002 Feb 22; 23(1-3):111-32. PubMed ID: 12373526 [Abstract] [Full Text] [Related]
14. Single high dose treatment with methotrexate causes long-lasting cognitive dysfunction in laboratory rodents. Fardell JE, Vardy J, Logge W, Johnston I. Pharmacol Biochem Behav; 2010 Dec 22; 97(2):333-9. PubMed ID: 20828582 [Abstract] [Full Text] [Related]
15. Memantine partly rescues behavioral and cognitive deficits in an animal model of neurodegeneration. Borre Y, Bosman E, Lemstra S, Westphal KG, Olivier B, Oosting RS. Neuropharmacology; 2012 Apr 22; 62(5-6):2010-7. PubMed ID: 22248638 [Abstract] [Full Text] [Related]
19. The effects of binge MDMA on acquisition and reversal learning in a radial-arm maze task. Kay C, Harper DN, Hunt M. Neurobiol Learn Mem; 2011 May 22; 95(4):473-83. PubMed ID: 21371565 [Abstract] [Full Text] [Related]
20. SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents. de Bruin NM, Prickaerts J, Lange JH, Akkerman S, Andriambeloson E, de Haan M, Wijnen J, van Drimmelen M, Hissink E, Heijink L, Kruse CG. Neurobiol Learn Mem; 2010 May 22; 93(4):522-31. PubMed ID: 20132903 [Abstract] [Full Text] [Related] Page: [Next] [New Search]